Sumitomo Mitsui Trust Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-444,985	Closed	-$4.96M	–	1256
2022 Q1	$4.96M	Sell	444,985 -120,205	-21%	-$1.36M	﹤0.01%	857
2021 Q4	$7.39M	Hold	565,190	–	–	﹤0.01%	802
2021 Q3	$7.36M	Hold	565,190	–	–	﹤0.01%	805
2021 Q2	$8.31M	Hold	565,190	–	–	﹤0.01%	804
2021 Q1	$6.94M	Hold	565,190	–	–	﹤0.01%	810
2020 Q4	$8.06M	Sell	565,190 -7,360	-1%	-$99.1K	0.01%	799
2020 Q3	$7.96M	Sell	572,550 -5,000	-0.9%	-$59.6K	0.01%	782
2020 Q2	$6.08M	Hold	577,550	–	–	﹤0.01%	786
2020 Q1	$4.66M	Hold	577,550	–	–	﹤0.01%	794
2019 Q4	$4.69M	Hold	577,550	–	–	﹤0.01%	806
2019 Q3	$4.38M	Buy	+577,550	New	+$4.3M	﹤0.01%	794
2016 Q1	–	Sell	-451,500	Closed	-$4.18M	–	884
2015 Q4	$4.18M	Sell	451,500 -1,038,320	-70%	-$11.4M	0.01%	681
2015 Q3	$19M	Buy	1,489,820 +319,500	+27%	+$3.97M	0.04%	524
2015 Q2	$12.9M	Buy	1,170,320 +380,500	+48%	+$4.2M	0.02%	629
2015 Q1	$9.02M	Buy	789,820 +701,820	+798%	+$7.44M	0.02%	637
2014 Q4	$880K	Buy	+88,000	New	+$926K	﹤0.01%	795

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Sumitomo Mitsui Trust Group's RDY Position: Q2 2022 in Review

Sumitomo Mitsui Trust Group sold out of Dr. Reddy's Laboratories (RDY) in Q2 2022, closing a stake of 444,985 shares — an estimated $4.96M sold.

Sumitomo Mitsui Trust Group first reported a position in RDY in Q4 2014 and held it in 16 quarters. The position peaked at $19M in Q3 2015. 148 funds tracked by Wall St. Rank hold RDY as of Q2 2022.

Sumitomo Mitsui Trust Group reported no remaining Dr. Reddy's Laboratories position as of Q2 2022 after selling out during the quarter.
Sumitomo Mitsui Trust Group sold 444,985 Dr. Reddy's Laboratories shares in Q2 2022, an estimated $4.96M.
Sumitomo Mitsui Trust Group first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 16 quarters.
Sumitomo Mitsui Trust Group's Dr. Reddy's Laboratories position peaked at $19M in Q3 2015.
148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2022.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2022, filed 26 Jul 2022.